An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials

Antonio L. Bartorelli; Patrick W. Serruys; Karine Miquel-Hébert; Shui Yu; Wes Pierson; Gregg W. Stone

doi:10.1002/ccd.22452

An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials

Antonio L. Bartorelli, Patrick W. Serruys, Karine Miquel-Hébert, Shui Yu, Wes Pierson, Gregg W. Stone

Centro Cardiologico Monzino

Research output: Contribution to journal › Article › peer-review

Abstract

Objectives: To evaluate the safety and efficacy of the XIENCE V everolimus-eluting stent compared to the TAXUS paclitaxel-eluting stent in small vessels. Backgroud: The XIENCE V everolimus-eluting stent (EES) has been shown to improve angiographic and clinical outcomes after percutaneous myocardial revascularization, but its performance in small coronary arteries has not been investigated. Methods: In this pooled analysis, we studied a cohort of 541 patients with small coronary vessels (reference diameter

Original language	English
Pages (from-to)	60-66
Number of pages	7
Journal	Catheterization and Cardiovascular Interventions
Volume	76
Issue number	1
DOIs	https://doi.org/10.1002/ccd.22452
Publication status	Published - Jul 1 2010

Keywords

Coronary arteries
Drug-eluting stents
Lumen loss
Small vessels

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Radiology Nuclear Medicine and imaging
Medicine(all)

Access to Document

10.1002/ccd.22452

Fingerprint Dive into the research topics of 'An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials'. Together they form a unique fingerprint.

Cite this

An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease : A pooled analysis from the SPIRIT II and SPIRIT III trials. / Bartorelli, Antonio L.; Serruys, Patrick W.; Miquel-Hébert, Karine; Yu, Shui; Pierson, Wes; Stone, Gregg W.

In: Catheterization and Cardiovascular Interventions, Vol. 76, No. 1, 01.07.2010, p. 60-66.

Research output: Contribution to journal › Article › peer-review

@article{e1c00be7d58c4584b3b78f6537af7666,

title = "An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials",

abstract = "Objectives: To evaluate the safety and efficacy of the XIENCE V everolimus-eluting stent compared to the TAXUS paclitaxel-eluting stent in small vessels. Backgroud: The XIENCE V everolimus-eluting stent (EES) has been shown to improve angiographic and clinical outcomes after percutaneous myocardial revascularization, but its performance in small coronary arteries has not been investigated. Methods: In this pooled analysis, we studied a cohort of 541 patients with small coronary vessels (reference diameter ",

keywords = "Coronary arteries, Drug-eluting stents, Lumen loss, Small vessels",

author = "Bartorelli, {Antonio L.} and Serruys, {Patrick W.} and Karine Miquel-H{\'e}bert and Shui Yu and Wes Pierson and Stone, {Gregg W.}",

year = "2010",

month = jul,

day = "1",

doi = "10.1002/ccd.22452",

language = "English",

volume = "76",

pages = "60--66",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",

publisher = "John Wiley and Sons Inc.",

number = "1",

}

TY - JOUR

T1 - An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease

T2 - A pooled analysis from the SPIRIT II and SPIRIT III trials

AU - Bartorelli, Antonio L.

AU - Serruys, Patrick W.

AU - Miquel-Hébert, Karine

AU - Yu, Shui

AU - Pierson, Wes

AU - Stone, Gregg W.

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Objectives: To evaluate the safety and efficacy of the XIENCE V everolimus-eluting stent compared to the TAXUS paclitaxel-eluting stent in small vessels. Backgroud: The XIENCE V everolimus-eluting stent (EES) has been shown to improve angiographic and clinical outcomes after percutaneous myocardial revascularization, but its performance in small coronary arteries has not been investigated. Methods: In this pooled analysis, we studied a cohort of 541 patients with small coronary vessels (reference diameter

AB - Objectives: To evaluate the safety and efficacy of the XIENCE V everolimus-eluting stent compared to the TAXUS paclitaxel-eluting stent in small vessels. Backgroud: The XIENCE V everolimus-eluting stent (EES) has been shown to improve angiographic and clinical outcomes after percutaneous myocardial revascularization, but its performance in small coronary arteries has not been investigated. Methods: In this pooled analysis, we studied a cohort of 541 patients with small coronary vessels (reference diameter

KW - Coronary arteries

KW - Drug-eluting stents

KW - Lumen loss

KW - Small vessels

UR - http://www.scopus.com/inward/record.url?scp=77954296416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954296416&partnerID=8YFLogxK

U2 - 10.1002/ccd.22452

DO - 10.1002/ccd.22452

M3 - Article

C2 - 20578194

AN - SCOPUS:77954296416

VL - 76

SP - 60

EP - 66

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 1

ER -

An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: A pooled analysis from the SPIRIT II and SPIRIT III trials

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this